Ligand Pharmaceuticals (LGND) Q4 2019 Earnings

5NovConfirmed
Q1 2019
Q2 2019
Q3 2019
Q4 2019
0.49
0.89
1.3
1.7

Details

Expected EPS
0.61
Actual EPS
0.49
Surprise EPS
-0.12
Surprise Percent
+19.67%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 0.49 per share for Q4 2019.

0 Comments

Share your thoughts